News
Advanced Cell Technology (ACT), an early leader in the field of regenerative medicine, recently published data in The Lancet that shows positive results from its ongoing stem cell transplantation trial. The clinical trial uses…
Read More about Regenerative Medicine Milestone: Stem Cell Clinical Trial Announces Positive Results
How would you describe what it feels like to see something? We have lots of language to help us with this. We can talk about colours, textures, shadows, scenery, and movement. We…
Read More about A New Kind of Vision
Babies born with Retinopathy of prematurity (ROP), one of the most common causes of vision loss in children, stand to benefit from an exciting discovery made possible, in part, by Fighting Blindness Canada. The…
Read More about Discovery Paves Road for New Treatments to Prevent Blindness in Babies
Clinical trials of valproic acid for the treatment of retinitis pigmentosa began in both the USA and Korea in late 2011. As well, a smaller shorter open-label trial was begun in Japan….
Read More about Valproic Acid as a Treatment for Retinitis Pigmentosa
In January, follow-up results from the first six months of the British choroideremia gene therapy trial were published. At the Association for Vision Research and Ophthalmology meeting today, the team led by Dr. Robert…
Read More about One Year Results of Choroideremia Gene Therapy Trial
The first human trial of a gene therapy for choroideremia has announced preliminary results on six people: two of these patients have experienced significant improvements in vision. The findings were published in…
Read More about First Gene Therapy Results for Choroideremia Suggest Cautious OptimismJoin the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
